Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cyrus Biotechnology

Request full access

Advanced computational software for protein modeling and design

Seattle, United StatesFounded 2014Biotech & Life Sciences

About Cyrus Biotechnology

Cyrus Biotechnology is a cutting-edge startup based in Seattle, specializing in advanced protein engineering and computational biology. The company primarily serves clients in the biopharmaceutical, synthetic biology, chemical, non-profit, academic, and consumer product sectors. These clients range from large pharmaceutical companies developing new drugs to academic researchers studying protein structures.

Cyrus operates in the highly specialized market of protein design and optimization. The company uses sophisticated computational methods to solve complex problems in protein engineering, such as protein stabilization, difficult protein structure prediction, and enzyme optimization. Their services are crucial for clients looking to bring new products or drugs to market faster and more efficiently.

The business model of Cyrus Biotechnology is flexible and client-centric. They offer a variety of solutions tailored to the specific needs of their clients. This includes partnership models where they share risks and rewards with their clients on well-defined projects, as well as independent project support where clients can use Cyrus's tools and expertise to achieve their goals.

Cyrus makes money by providing these specialized services and solutions. They charge fees for their computational tools, consulting services, and collaborative projects. By helping their clients solve difficult protein-related problems, Cyrus adds significant value, enabling faster and more cost-effective development of new products and therapies.

In summary, Cyrus Biotechnology leverages advanced computational methods to assist a diverse range of clients in the biopharma and related industries, offering flexible business models to meet varied needs.

Source: Dealroom company data

At a glance

Status
Operational
Employees
17
Open positions
None listed
Dealroom signal
64.5/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Modeling, Developer Tools, Biotechnology, Molecular, Synthetic Biology, Spinout, Macro-Nutrients
Technology
Deep Tech
Business model
Manufacturing, SaaS
Client focus
B2C
Investment activity
1 company, latest Dec 2021
Capital deployed
—
Preferred round
ACQUISITION

Funding history

8 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Dec 2021 $18M $72M Family Offices Today · The Yard Ventures · iSelect Fund · Selecta Biosciences ↗
LATE VCEquity / VC Jul 2021 $16M $64M Undisclosed —
Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

Cyrus Biotechnology website traffic

Latest recorded traffic for Cyrus Biotechnology is 3K monthly website visits, down 25% over the last three months. Cyrus Biotechnology's team declined 29.2% over the past year.

Latest monthly visits3K 3-month web change-25% 1-year team growth-29.2%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Fluidic AnalyticsDevelops microfluidic tools for protein analysis in research and clinical applications Cambridge, United Kingdom Acquired 10 $39M —
VALANX BiotechVALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development Vienna, Austria Operational
CardiaTecApplying artificial intelligence on large-scale human multiomic data to develop the next generation of cardiovascular disease targets Cambridge, United Kingdom Operational
AI ProteinsA newly founded biotechnology company focused on the design and engineering of synthetic miniprotein therapeutics Andover, United States Operational
Adaptyv BiosystemsDesigns and builds custom proteins for a variety of applications Lausanne, Switzerland Operational
PhoreMostA new-model drug discovery company based in Cambridge, UK Pampisford, United Kingdom Operational
BetagenonA biopharmaceutical company focused on the development of activated protein kinase activator compounds to treat metabolic and cardiorenal, and inflammatory disorders associated with obesity and aging Umeå kommun, Sweden Operational
NanoSyrinxA cutting-edge synthetic biology company creating the next generation of targeted drug delivery systems to address challenges in the biologic delivery sector Coventry, United Kingdom Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Cyrus Biotechnology in the Seattle ecosystem

Live from Dealroom

The Cyrus Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

14 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • WINGS
  • The W Fund

Series A8 investors entered at this stage

  • Trinity Ventures
  • SpringRock Ventures
  • OrbiMed
  • Family Offices Today
  • The Yard Ventures
  • iSelect Fund
  • Selecta Biosciences
  • Agent Capital

Other known investors4 additional known investors

  • University of Illinois Urbana Champaign
  • University of Washington
  • Alumni Ventures
  • Sahsen Ventures
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Cyrus Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cyrus Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.